Overexpressed BCAR4 has been reported in cervical cancer, non-small cell lung cancer (NSCLC), and gastric cancer, suggesting that it may be a biomarker for poor prognosis (Wang et al., 2017; Yang et al., 2018; Zou et al., 2018). Here, BCAR4 is linked to cervical cancer.